Pharmacokinetics of a Concentrated Buprenorphine Formulation in Red-Tailed Hawks (Buteo jamaicensis)
American Association of Zoo Veterinarians Conference 2017
Molly D. Gleeson1, DVM; David Sanchez-Migallon Guzman2, LV, MS, DECZM (Avian), DECZM (Small Mammal), DACZM; Heather K. Knych3, DVM, PhD; Philip H. Kass4, DVM, PhD, DACVPM; Tracy L. Drazenovich5, DVM; Michelle G. Hawkins6, VMD, DABVP (Avian Practice)
1William R. Pritchard Veterinary Medical Teaching Hospital, 2,3,5,6Department of Medicine and Epidemiology, the 3K.L. Maddy Equine Analytical Chemistry Laboratory, and 4Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, USA

Abstract

Opioid drugs are the cornerstone therapy for moderate to severe pain management, and recent studies have shown mu opioid agonists to be effective in some raptor species.1-3 The pharmacokinetics of two doses of a concentrated formulation of buprenorphine (Simbadol™, 0.3 mg/kg SC)a were evaluated in red-tailed hawks (Buteo jamaicensis, n=6). Blood samples were collected at 10 timepoints over a 24-hour period after drug administration to determine buprenorphine plasma concentrations using liquid chromatography-tandem mass spectrometry. After a 4-week washout period, the same birds were administered 1.8 mg/kg SC of the same formulation. Blood samples were collected at 13 timepoints over a 96-hour period after drug administration. The hawks were monitored for adverse effects and assigned a sedation/agitation score at each timepoint. Maximum buprenorphine concentration was achieved at 5 and 15 minutes for the 0.3 mg/kg and 1.8 mg/kg doses, and plasma concentrations were maintained above 1 ng/ml for at least 24 and 48 hours, respectively. The elimination half-life was 7.12 and 8.74 hours for the low and high doses. There were significantly higher sedation scores for both doses (p<0.001) at the timepoints evaluated between 15 minutes and 48 hours. No adverse effects were noted in any birds. In summary, the formulation evaluated results in rapid absorption of buprenorphine and plasma concentrations above 1 ng/ml for 24 and 48 hours following administration of 0.3 and 1.8 mg/kg SC, respectively, causing mild to moderate sedation in red-tailed hawks.

Endnotes

a. Simbadol™ 1.8 mg/ml buprenorphine, Zoetis, Parsippany, NJ, USA

Acknowledgments

The authors would like to thank the California Raptor Center for their dedicated care of the hawks used in this study and assistance with data collection.

Literature Cited

1.  Ceulemans SM, Guzman DS, Olsen GH, Beaufrère H, Paul-Murphy JR. Evaluation of thermal antinociceptive effects after intramuscular administration of buprenorphine hydrochloride to American kestrels (Falco sparverius). Am J Vet Res. 2014;75:705–710.

2.  Guzman DS, Drazenovich TL, Olsen GH, Willits NH, Paul-Murphy JR. Evaluation of thermal antinociceptive effects after intramuscular administration of hydromorphone hydrochloride to American kestrels (Falco sparverius). Am J Vet Res. 2013;74:817–822.

3.  Guzman DS, Drazenovich TL, Olsen GH, Willits NH, Paul-Murphy JR. Evaluation of thermal antinociceptive effects after oral administration of tramadol hydrochloride to American kestrels (Falco sparverius). Am J Vet Res. 2014;75:117–123.

 

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Molly D. Gleeson, DVM
William R. Pritchard Veterinary Medical Teaching Hospital
School of Veterinary Medicine
University of California
Davis, CA, USA


MAIN : Avian Medicine : Concentrated Buprenorphine in Red-Tailed Hawks
Powered By VIN
SAID=27